title: A novel serotonin blocker, sarpogrelate, increases circulating adiponectin levels in diabetic patients with arteriosclerosis obliterans.
authors.forename: Jun'ichi
authors.initials: J
authors.lastname: Yamakawa
authors.forename: Takashi
authors.initials: T
authors.lastname: Takahashi
authors.forename: Tohoru
authors.initials: T
authors.lastname: Itoh
authors.forename: Kazuya
authors.initials: K
authors.lastname: Kusaka
authors.forename: Ken
authors.initials: K
authors.lastname: Kawaura
authors.forename: Xin Qui
authors.initials: XQ
authors.lastname: Wang
authors.forename: Tsugiyasu
authors.initials: T
authors.lastname: Kanda
mesh_terms: D052242:Adiponectin; D000368:Aged; D001162:Arteriosclerosis Obliterans / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications*; D005260:Female; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins; D008297:Male; D008875:Middle Aged; D011506:Proteins / Q000378:metabolism*; D012702:Serotonin Antagonists / Q000627:therapeutic use*; D013386:Succinates / Q000627:therapeutic use*
chemical_list: D052242:Adiponectin; D036341:Intercellular Signaling Peptides and Proteins; D011506:Proteins; D012702:Serotonin Antagonists; D013386:Succinates; C064294:sarpogrelate